次世代がん診断の世界市場の規模と予測:技術別(NGS、LOACおよびRT-PCR)、用途別(CTC、バイオマーカー)、がん別(肺、乳房)、機能コンパニオン診断別、動向分析、2013-2024...市場調査レポートについてご紹介

【英文タイトル】Next Generation Cancer Diagnostics Market Size & Forecasts By Technology (NGS, LOAC & RT-PCR), By Application (CTC, Biomarker), By Cancer Type (Lung, Breast), By Function Companion Diagnostics), And Trend Analysis, 2013 - 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Next Generation Cancer Diagnostics Industry Outlook
2.1 Market segmentation
2.2 Market size and growth prospects, 2013 – 2024
2.3 Next generation cancer diagnostics market dynamics
2.3.1 Market driver analysis
2.3.1.1 Exponentially decreasing cost of genetic sequencing
2.3.1.2 Development of cluster chip technology and potential applications of CTC in cancer management
2.3.1.3 Rising demand for preventive medicine & companion diagnostics
2.3.1.4 Growing cancer incidence
2.3.2 Market restraint analysis
2.3.2.1 Requirement of expensive laboratory set-up for implementation of novel tests
2.4 Key Opportunities Prioritized
2.5 Industry analysis – Porter’s
2.6 Next Generation Cancer Diagnostics PESTEL Analysis
Chapter 3 Next Generation Cancer Diagnostics Technology Outlook
3.1 Global next generation cancer diagnostics revenue share, by technology, 2015 & 2024
3.2 NGS-based cancer diagnostics
3.2.1 NGS-based cancer diagnostics market, 2013 – 2024 (USD Million)
3.3 qPCR & Multiplexing
3.3.1 qPCR & multiplexing-based market, 2013 – 2024 (USD Million)
3.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
3.4.1 LOAC & RT-PCR-based market, 2013 – 2024 (USD Million)
3.5 Protein microarrays-based cancer diagnostics
3.5.1 Protein microarraysmarket, 2013 – 2024 (USD Million)
3.6 DNA microarrays-based cancer diagnostics
3.6.1 DNAmicroarrays-based cancer diagnosticsmarket, 2013 – 2024 (USD Million)
Chapter 4 Next Generation Cancer Diagnostics Outlook by Cancer Type
4.1 Global next generation cancer diagnostics revenue share, by cancer type, 2015&2024
4.2 Lung cancer
4.2.1 NGCD for lung cancer market, 2013 – 2024 (USD Million)
4.3 Breast cancer
4.3.1 NGCD for breast cancer market, 2013 – 2024 (USD Million)
4.4 Colorectal cancer
4.4.1 NGCD for colorectal cancer market, 2013 – 2024 (USD Million)
4.5 Cervical cancer
4.5.1 NGCD for cervical cancer market, 2013 – 2024 (USD Million)
4.6 Other types of cancer
4.6.1 NGCD for other forms of cancer market, 2013 – 2024 (USD Million)
Chapter 5 Next Generation Cancer Diagnostics Outlook by Application Outlook
5.1 Global next generation cancer diagnostics revenue share, by application, 2015&2024
5.2 Biomarker development
5.2.1 NGCD for biomarker development market, 2013 – 2024 (USD Million)
5.3 CTC analysis
5.3.1 NGCD for CTC analysis market, 2013 – 2024 (USD Million)
5.4 Proteomic analysis
5.4.1 NGCD for proteomic analysis market, 2013 – 2024 (USD Million)
5.5 Epigenetic analysis
5.5.1 NGCD for epigenetic analysis market, 2013 – 2024 (USD Million)
5.6 Genetic analysis
5.6.1 NGCD for genetic analysismarket, 2013 – 2024 (USD Million)
Chapter 6 Next Generation Cancer Diagnostics Outlook by Function
6.1 Global next generation cancer diagnostics revenue share, by function, 2015&2024
6.2 Therapeutic monitoring
6.2.1 NGCD for therapeutic monitoring market, 2013 – 2024 (USD Million)
6.3 Companion diagnostics
6.3.1 NGCD for companion diagnostics market, 2013 – 2024 (USD Million)
6.4 Prognostic diagnostics
6.4.1 NGCD for prognostics market, 2013 – 2024 (USD Million)
6.5 Cancer screening
6.5.1 NGCD for cancer screening market, 2013 – 2024 (USD Million)
6.6 Risk analysis
6.6.1 NGCD for risk analysis market, 2013 – 2024 (USD Million)
Chapter 7 Next Generation Cancer Diagnostics Regional Outlook
7.1 Global next generation cancer diagnostics revenue share, by region, 2015 & 2024
7.2 North America
7.2.1 North America next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canada next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.3 Europe
7.3.1 Europe next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.3.3 France
7.3.3.1 France next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan next generation cancer diagnosticsmarket, 2013 – 2024 (USD Million)
7.4.3 China
7.4.3.1 China next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.5 Latin America
7.5.1 Latin Americanext generation cancer diagnosticsmarket, 2013 – 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.6 MEA
7.6.1 MEA next generation cancer diagnostics market, 2013 – 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa next generation cancer diagnostics market, 2013 – 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Janssen Global Services, LLC
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 F. Hoffmann-La Roche Ltd
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Abbott
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.6 GE Healthcare
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Thermo Fisher Scientific, Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Agilent Technologies (Dako)
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 Strategic Initiatives
8.9 Illumina, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Qiagen
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
8.11 Cepheid
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.11.4 Strategic Initiatives
8.12 Opko Health, Inc.
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Service Benchmarking
8.12.4 Strategic Initiatives
8.13 Hologic, Inc (Gen-Probe)
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.13.4 Strategic Initiatives
8.14 Perkin Elmer, Inc.
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiatives
8.15 Sysmex Corporation
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiatives
8.16 Myriad Genetics, Inc.
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3 Product Benchmarking
8.16.4 Strategic Initiatives
8.17 Almac Group
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.17.4 Strategic Initiatives
8.18 Exosome Diagnostics, Inc.
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
8.19 Genomic Health, Inc.
8.19.1 Company Overview
8.19.2 Financial Performance
8.19.3 Product Benchmarking
8.19.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:次世代がん診断の世界市場の規模と予測:技術別(NGS、LOACおよびRT-PCR)、用途別(CTC、バイオマーカー)、がん別(肺、乳房)、機能コンパニオン診断別、動向分析、2013-2024
■ 英文:Next Generation Cancer Diagnostics Market Size & Forecasts By Technology (NGS, LOAC & RT-PCR), By Application (CTC, Biomarker), By Cancer Type (Lung, Breast), By Function Companion Diagnostics), And Trend Analysis, 2013 - 2024
■ 発行日:2017年1月4日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707584
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。